A recent study conducted by Ki Cheol Chang, M.D., of Seoul National University in South Korea, and colleagues, found that patients taking amantadine, which is used as a treatment for Parkinson's disease, are at a risk for damaging their corneal endothelium (which is the inner layer of the clear dome over the colored portion of the eye.) This can lead to impaired vision. Based on the study, the damage that can occur appears to be worsened by the total amount of the drug that is used over time, as well as, the longer it is used for.
If you or someone you know is taking amantadine please schedule or tell them to schedule an appointment with one of our Eye Care Professionals to evaluate for possible corneal damage.
Alan Szczesniewski, D.O. F.A.O.C.O.